Vivo Bio Tech secures pre-clinical testing contract valued at Rs.10.75 Cr
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies
Its lead product, Dasynoc, is awaiting FDA approval with a PDUFA date of October 7, 2025
The coating is designed for heat-sealable applications, offering oil and grease resistance on kraft paper and suitable blister coatings for paper and paperboard
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
The CDMO upgrade represents a transformational step for Remedium Lifecare
Subscribe To Our Newsletter & Stay Updated